# A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects

> **NCT01739647** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 72 (actual)

## Conditions studied

- Healthy Young Volunteers
- Healthy Elderly Volunteers

## Interventions

- **DRUG:** AZD3293
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01739647
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2013-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01739647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01739647, "A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01739647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*